Rosuvastatin
Sold as Crestor, Zuvamor, Cresagen, Vusor, Storwin, Rosuvastatin ran, Rostor, Rosuvastatin unicorn, Crevas, Rocrest, Ruvacrest, Rovalip, Rosuvastatin cipla, Zyrova, Torus, Vusor od, Coleros, Lupovas, Rosuvakem
(E,3R,5S)-7-[4-(4-Fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid
Drag to rotate. Structure from PubChem CID 446157.
Background
Registration
- Applicants
- 17
- Registrations
- 71
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Astrazeneca Pharmaceuticals (Pty) Ltd | Crestor | 5, 10, 20, 40 | 360349, 360350, 360351, 410298 | S4 | PIPIL |
| Acino Pharma (Pty) LtdCertificate held by Acino Pharma (Pty) Ltd. | Zuvamor | 5, 10, 20, 40 | 360353, 360354, 360355, 431138 | S4 | PIPIL |
| Trinity Pharma (Pty) LtdCertificate held by Trinity Pharma (Pty) Ltd. | Cresagen, Torus | 5, 10, 20, 40 | 441065, 441067, 441068, 491131, 491132 | S4 | PIPIL |
| Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Trinity Pharma (Pty) Ltd | Cresagen | 10 | 441066 | S4 | PIPIL |
| Teva Pharmaceuticals (Pty) Ltd | Vusor, Vusor od | 5, 10, 20, 40 | 450310, 450311, 450312, 450313, 530268, 530269, 530270, 530271 | S4 | PIPIL |
| Sanofi-aventis South Africa (Pty) Ltd | Storwin | 10 mg, 20 mg, 40 mg | 450502, 450503, 450504 | Not determined | None |
| Ranbaxy (SA) (Pty) Ltd | Rosuvastatin ran | 5, 10, 20, 40 | 450959, 450960, 450961, 450962 | Not determined | None |
| Viatris South Africa (Pty) Ltd | Rostor | 5 mg, 10 mg, 20 mg, 40 mg | 460222, 460223, 460224, 460225 | Not determined | None |
| Sandoz South Africa (Pty) LtdCertificate held by Sandoz SA (Pty) Ltd1 | Rosuvastatin unicorn, Rovalip | 5mg/10mg/20mg/40mg, 5, 10, 20, 40 | 460307, 460308, 460309, 460310, 460893, 460894, 460895, 460896 | S4 | PIPIL |
| Pharma Dynamics (Pty) Ltd | Crevas | 5/10/20/40 mg | 460313, 460314, 460315, 460316, 550453 | S4 | PIPIL |
| Austell Pharmaceuticals (Pty) Ltd | Rocrest | 10, 20, 40 | 460326, 460327, 460328 | S4 | None |
| Activo Health (Pty) Ltd | Ruvacrest | 10 mg, 20 mg, 40 mg | 460432, 460433, 460434 | Not determined | None |
| Cipla Medpro (Pty) Ltd | Rosuvastatin cipla | 5/10/20/40 mg | 480188, 480189, 480190, 480191 | S4 | PIPIL |
| Zydus Healthcare (Pty) Ltd | Zyrova | 5 / 10 / 20 mg | 490469, 490470, 490471 | S4 | PIPIL |
| Unimed Healthcare (Pty) LtdCertificate held by Ipharma (Pty) Ltd | Coleros | 5/10/20/40 mg | 550022, 550023, 550024, 550025 | S4 | PIPIL |
| Innovata pharmaceuticals | Lupovas | 5, 10, 20, 40 | 550563, 550564, 550565, 550566 | Not determined | None |
| Ascend Laboratories (Pty) Ltd | Rosuvakem | 5, 10, 20, 40 | 560867, 560868, 560869, 560870 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Crestor 10 EACH TABLET CONTAINS ROSUVASTATIN 10,0 mg | 10Film-coated tablets | 36034936/7.5/0349Approved 5 August 2022 | Registered | S4 | PIPIL |
| Crestor 20 EACH TABLET CONTAINS ROSUVASTATIN 20,0 mg | 20Film-coated tablets | 36035036/7.5/0350Approved 5 August 2022 | Registered | S4 | PIPIL |
| Crestor 40 EACH TABLET CONTAINS ROSUVASTATIN 40,0 MG | 40Film-coated tablets | 36035136/7.5/0351Approved 5 August 2022 | Registered | S4 | PIPIL |
| Zuvamor 10 EACH TABLET CONTAINS ROSUVASTATIN 10,0 mg | 10Film-coated tablets | 36035336/7.5/0353Approved 23 October 2024 | Registered | S4 | PIPIL |
| Zuvamor 20 EACH TABLET CONTAINS ROSUVASTATIN 20,0 mg | 20Film-coated tablets | 36035436/7.5/0354Approved 23 October 2024 | Registered | S4 | PIPIL |
| Zuvamor 40 EACH TABLET CONTAINS ROSUVASTATIN 40,0 mg | 40Film-coated tablets | 36035536/7.5/0355Approved 23 October 2024 | Registered | S4 | PIPIL |
| Crestor 5 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5Film-coated tablets | 41029841/7.5/0298Approved 5 August 2022 | Registered | S4 | PIPIL |
| Zuvamor 5 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5Film-coated tablets | 43113843/7.5/1138Approved 23 October 2024 | Registered | S4 | PIPIL |
| Cresagen 5 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5Film-coated tablets, | 44106544/7.5/1065Approved 25 November 2023 | Registered | S4 | PIPIL |
| Cresagen 10 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 10Film-coated tablets, | 44106644/7.5/1066Approved 25 November 2023 | Registered | S4 | PIPIL |
| Cresagen 20 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 20Film-coated tablets, | 44106744/7.5/1067Approved 25 November 2023 | Registered | S4 | PIPIL |
| Cresagen 40 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 40Film-coated tablets, | 44106844/7.5/1068Approved 25 November 2023 | Registered | S4 | PIPIL |
| Vusor 5 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5Film-coated tablets | 45031045/7.5/0310Approved 29 May 2023 | Registered | S4 | PIPIL |
| Vusor 10 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 10Film-coated tablets | 45031145/7.5/0311Approved 29 May 2023 | Registered | S4 | PIPIL |
| Vusor 20 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 20Film-coated tablets | 45031245/7.5/0312Approved 29 May 2023 | Registered | S4 | PIPIL |
| Vusor 40 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 40Film-coated tablets | 45031345/7.5/0313Approved 29 May 2023 | Registered | S4 | PIPIL |
| Storwin 10 MG EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 10 mg | 45050245/7.5/0502 | Registered | Not determined | None |
| Storwin 20 MG EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 20 mg | 45050345/7.5/0503 | Registered | Not determined | None |
| Storwin 40 MG EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 40 mg | 45050445/7.5/0504 | Registered | Not determined | None |
| Rosuvastatin ran 5 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5 | 45095945/7.5/0959 | Registered | Not determined | None |
| Rosuvastatin ran 10 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 10 | 45096045/7.5/0960 | Registered | Not determined | None |
| Rosuvastatin ran 20 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 20 | 45096145/7.5/0961 | Registered | Not determined | None |
| Rosuvastatin ran 40 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 40 | 45096245/7.5/0962 | Registered | Not determined | None |
| Rostor 5 MG EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5 mg | 46022246/7.5/0222 | Registered | Not determined | None |
| Rostor 10 MG EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 10 mg | 46022346/7.5/0223 | Registered | Not determined | None |
| Rostor 20 MG EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 20 mg | 46022446/7.5/0224 | Registered | Not determined | None |
| Rostor 40 MG EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 40 mg | 46022546/7.5/0225 | Registered | Not determined | None |
| Rosuvastatin unicorn 5 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5mg/10mg/20mg/40mgFilm-coated tablets | 46030746/7.5/0307Approved 12 May 2022 | Registered | S4 | PIPIL |
| Rosuvastatin unicorn 10 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 5mg/10mg/20mg/40mgFilm-coated tablets | 46030846/7.5/0308Approved 12 May 2022 | Registered | S4 | PIPIL |
| Rosuvastatin unicorn 20 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 5mg/10mg/20mg/40mgFilm-coated tablets | 46030946/7.5/0309Approved 12 May 2022 | Registered | S4 | PIPIL |
| Rosuvastatin unicorn 40 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 5mg/10mg/20mg/40mgFilm-coated tablets | 46031046/7.5/0310Approved 12 May 2022 | Registered | S4 | PIPIL |
| Crevas 5 MG Each film-coated tablet contains ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5/10/20/40 mgTablet | 46031346/7.5/0313Approved 27 August 2025 | Registered | S4 | PIPIL |
| Crevas 10 MG Each film-coated tablet contains ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 5/10/20/40 mgTablet | 46031446/7.5/0314Approved 27 August 2025 | Registered | S4 | PIPIL |
| Crevas 20 MG Each film-coated tablet contains ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 5/10/20/40 mgTablet | 46031546/7.5/0315Approved 27 August 2025 | Registered | S4 | PIPIL |
| Crevas 40 MG Each film-coated tablet contains ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 5/10/20/40 mgTablet | 46031646/7.5/0316Approved 27 August 2025 | Registered | S4 | PIPIL |
| Rocrest 10 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM 10,0 mg | 10 | 46032646/7.5/0326 | Registered | S4 | None |
| Rocrest 20 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM 20,0 mg | 20 | 46032746/7.5/0327 | Registered | S4 | None |
| Rocrest 40 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM 40,0 mg | 40 | 46032846/7.5/0328 | Registered | S4 | None |
| Ruvacrest 10 MG EACH TABLET CONTAINS : ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 10 mg | 46043246/7.5/0432 | Registered | Not determined | None |
| Ruvacrest 20 MG EACH TABLET CONTAINS : ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 20 mg | 46043346/7.5/0433 | Registered | Not determined | None |
| Ruvacrest 40 MG EACH TABLET CONTAINS : ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 40 mg | 46043446/7.5/0434 | Registered | Not determined | None |
| Rovalip 5 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5 | 46089346/7.5/0893 | Registered | Not determined | None |
| Rovalip 10 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 10 | 46089446/7.5/0894 | Registered | Not determined | None |
| Rovalip 20 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 20 | 46089546/7.5/0895 | Registered | Not determined | None |
| Rovalip 40 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 40 | 46089646/7.5/0896 | Registered | Not determined | None |
| Rosuvastatin 5 cipla | 5/10/20/40 mgFilm-coated tablets | 48018848/7.5/0188Approved 2 August 2024 | Registered | S4 | PIPIL |
| Rosuvastatin 10 cipla | 5/10/20/40 mgFilm-coated tablets | 48018948/7.5/0189Approved 2 August 2024 | Registered | S4 | PIPIL |
| Rosuvastatin 20 cipla | 5/10/20/40 mgFilm-coated tablets | 48019048/7.5/0190Approved 2 August 2024 | Registered | S4 | PIPIL |
| Rosuvastatin 40 cipla | 5/10/20/40 mgFilm-coated tablets | 48019148/7.5/0191Approved 2 August 2024 | Registered | S4 | PIPIL |
| Zyrova 5 | 5 / 10 / 20 mgFilm-coated tablets | 49046949/7.5/0469Approved 21 July 2023 | Registered | S4 | PIPIL |
| Zyrova 10 | 5 / 10 / 20 mgFilm-coated tablets | 49047049/7.5/0470Approved 21 July 2023 | Registered | S4 | PIPIL |
| Zyrova 20 | 5 / 10 / 20 mgFilm-coated tablets | 49047149/7.5/0471Approved 21 July 2023 | Registered | S4 | PIPIL |
| Torus 10 | 10Film-coated tablet | 49113149/7.5/1131Approved 25 February 2023 | Registered | S4 | PIPIL |
| Torus 20 | 20Film-coated tablet | 49113249/7.5/1132Approved 25 February 2023 | Registered | S4 | PIPIL |
| Vusor 5 od EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5 | 53026853/7.5/0268 | Registered | Not determined | None |
| Vusor 10 od EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 10 | 53026953/7.5/0269 | Registered | Not determined | None |
| Vusor 20 od EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 20 | 53027053/7.5/0270 | Registered | Not determined | None |
| Vusor 40 od EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 40 | 53027153/7.5/0271 | Registered | Not determined | None |
| Coleros 5 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5/10/20/40 mgFilm-coated tablets | 55002255/7.5/0022Approved 20 July 2023 | Registered | S4 | PIPIL |
| Coleros 10 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 5/10/20/40 mgFilm-coated tablets | 55002355/7.5/0023Approved 20 July 2023 | Registered | S4 | PIPIL |
| Coleros 20 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 5/10/20/40 mgFilm-coated tablets | 55002455/7.5/0024Approved 20 July 2023 | Registered | S4 | PIPIL |
| Coleros 40 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 5/10/20/40 mgFilm-coated tablets | 55002555/7.5/0025Approved 20 July 2023 | Registered | S4 | PIPIL |
| Crevas 15 MG EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 15,0 mg | 5/10/20/40 mgTablet | 55045355/7.5/0453Approved 27 August 2025 | Registered | S4 | PIPIL |
| Lupovas 5 EACH TABLET CONTAINS ROSUVASTATIN 5,0 mg | 5 | 55056355/7.5/0563 | Registered | Not determined | None |
| Lupovas 10 EACH TABLET CONTAINS ROSUVASTATIN 10,0 mg | 10 | 55056455/7.5/0564 | Registered | Not determined | None |
| Lupovas 20 EACH TABLET CONTAINS ROSUVASTATIN 20,0 mg | 20 | 55056555/7.5/0565 | Registered | Not determined | None |
| Lupovas 40 EACH TABLET CONTAINS ROSUVASTATIN 40,0 mg | 40 | 55056655/7.5/0566 | Registered | Not determined | None |
| Rosuvakem 5 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg | 5 | 56086756/7.5/0867 | Registered | Not determined | None |
| Rosuvakem 10 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg | 10 | 56086856/7.5/0868 | Registered | Not determined | None |
| Rosuvakem 20 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg | 20 | 56086956/7.5/0869 | Registered | Not determined | None |
| Rosuvakem 40 EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg | 40 | 56087056/7.5/0870 | Registered | Not determined | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Rosuvastatin
S4: Ezetimibe
Consolidated Schedules 06 July 2026, line 6302
S4: Rosuvastatin
Consolidated Schedules 06 July 2026, line 7853
Pharmacological class: Serum-cholesterol reducers. (class 7.5)
Matched through the component Ezetimibe.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Crestor 10, Astrazeneca Pharmaceuticals (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.